Disclaimer: This page is intended for healthcare professionals only.

RESOURCES

Webinars

Downloads

Consultation Form

Empower your female patients suffering from cystitis with easy-to-understand Cystoplus® information

Enhance your patient consultations by providing this informative handout, titled Cystoplus® over-the-counter relief for women on the go. This resource clearly explains what Cystoplus® is, how it works and how to use it effectively.

Download now
Consultation Form
Product information sheet for pharmacists

Product information sheet for pharmacists

Access at-a-glance Cystoplus® care information.

Add the Patient recommendations for symptomatic relief of burning and stinging associated with cystitis in women product information sheet to your go-to resources for cystitis care. It provides quick details about Cystoplus® to help you support patients in managing symptoms.

Download now
Stepwise care approach from the CPhA*

Stepwise care approach from the CPhA*

Want to know how you can help your patients with uncomplicated UTIs?

This stepwise care approach is designed to help pharmacists assess, recommend and, where authorized, prescribe appropriate therapy for acute uncomplicated cystitis.

Download now
A guide to classifying UTIs from the CPhA*

A guide to classifying UTIs from the CPhA*

Want to know how to determine if a UTI is uncomplicated or complicated?

This practice tool is designed to help pharmacists accurately classify UTIs during patient assessment.

Download now
  • *CPhA= Canadian Pharmacists Association

References:

  1. Health Canada. Cystoplus Sodium Citrate Powder Product Licence. Issued, August 10, 2012.

Disclaimers

  • Cystoplus® is recommended for symptomatic relief of burning and stinging associated with cystitis in adult women.1
  • If patients have more than just mild symptoms (for example: painful urination, blood in urine or side pain, fever and chills, nausea and vomiting), or if symptoms persist or return soon after completing the 48-hour treatment, they should consult their health care practitioner. Cystoplus® is contraindicated in individuals taking lithium of hexamine, are on a low-sodium diet, are sensitive to any of the ingredients, if they are pregnant or breastfeeding, and in men and children.1
  • Although Cystoplus® Sodium Citrate Powder is not contraindicated for use with antibiotics, patients should always inform their primary care provider if they are taking any other medication. Due to its alkalizing effect on urine, sodium citrate can affect the excretion of certain antibiotics and alter their pharmacokinetic profiles.
  • Always direct the patient to read the label.
  • For more information: See Warnings, Cautions, and Directions of Use at https://health-products.canada.ca/lnhpd-bdpsnh/info?licence=80034529 for information to assist in benefit-risk assessment. The terms of Market Authorization are also available upon request by calling 1-888-550-6060.